Characterization of Vabicaserin (SCA-136), a Selective 5-Hydroxytryptamine 2C Receptor Agonist-Reference-Cited by-同舟云学术

Characterization of Vabicaserin (SCA-136), a Selective 5-Hydroxytryptamine 2C Receptor Agonist

Published:2011-03-14 Issue:3 Volume:337 Page:673-680
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Dunlop John,Watts Stephanie W.,Barrett James E.,Coupet Joseph,Harrison Boyd,Mazandarani Hossein,Nawoschik Stanley,Pangalos Menelas N.,Ramamoorthy Siva,Schechter Lee,Smith Deborah,Stack Gary,Zhang Jean,Zhang Guoming,Rosenzweig-Lipson Sharon

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference21 articles.

1. A review of central 5-HT receptors and their function

2. 5-HT2 receptor subtypes: A family re-united?

3. Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle;Baxter;Br J Pharmacol,1994

4. Pleiotropic Behavior of 5-HT2A and 5-HT2C Receptor Agonists

5. 5-HT2B receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments;Pharmacopsychiatry;2024-05-06

2. Pharmacotherapy and Emerging Treatment Strategies for Schizophrenia;Cognizance of Schizophrenia:: A Profound Insight into the Psyche;2023

3. Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence;Progress in Brain Research;2021

4. Has the bloom gone out of lorcaserin following the CAMELLIA-TIMI61 trial?;Expert Opinion on Pharmacotherapy;2020-12-31

5. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function;Pharmacological Reviews;2020-12-22